A number of alkyl and acyl derivatives of 4-dihydro-4-deoxy-4(R)-amino spectinomycin were tested against various Escherichia coli strains, possessing different susceptibilities to spectinomycin. The influence of the lipophilicity and the length of the side chain substituents of the derivatives was compared to both minimal inhibitory concentration values and stability to adenyltransferase. Derivatives with a chain length of more than 10 carbon atoms demonstrated a significantly higher activity against all investigated strains, whether susceptible or resistant. The same inhibitory effect was achieved with short-chain aminoacyl derivatives only against susceptible strains. Other short-chain derivatives possessed no aidvantage to spectinomycin. A 10-fold decrease in the affinity for adenyltransferase was achieved in compounds with a high lipophilicity (log P), i.e., in aliphatic substituted derivatives with a log P > 4 and in benzoyl-substituted derivatives with a log P > 2. Derivatives with branched alkyl chains and long side chains displayed a different mode of action than spectinomycin. They possessed strong activity against strains with an altered ribosomal binding site arid a decreased influence of pH on antimicrobial activity.
Spectinomycin is produced by either Streptomyces spectabilis (6, 36) or Streptomyces flavopersicus (26) . The antibiotic possesses a broad spectrum of activity against gram-positive and gram-negative bacteria, but particularly low potency against Pseudomonas species (10, 34) . Anaerobic strains are only slightly affected (29) . Increase of the pH of the culture medium up to pH 7.6 correlates with the antibacterial effect, implying that only the uncharged compound is biologically active (22) . Compared to streptomycin, the bacteriostatic effect of spectinomycin might be explained by reversible and slow binding to the 30S subunit of the ribosome (15, 23, 28) . Besides this bacteriostatic effect, spectinomycin is bactericidal for gonococci, causing cell lysis due to structural damage of the cytoplasmic membrane (33) . Therefore, the antibiotic is currently used in treatment of gonorrhoea (7, 9, 20) , particularly with the increasing penicillin resistance of these pathogens (2, 5, 31) .
Spectinomycin resistance in spontaneous mutants results from altered binding on the 30S ribosomal subunit or a change in permeability (23, 24) . In Escherichia coli K-12 spectinomycin-resistant mutants, ribosomal protein S5 is altered (3, 13) . Although S5 consists of about 180 amino acids, amino acid alterations in resistant ribosomes occur only over a short segment (valine-serine-lysine) of peptide T10. Thus, in spectinomycin-resistant mutant E. coli spec 7, serine is replaced by proline, whereas in E. coli spec 13 , valine is changed to glutamic acid (13, 14) .
R-plasmid-mediated resistance to spectinomycin is caused by adenyltransferase modification, apparently at the 9-position, similar to adenylation of the 3"-OH group in streptomycin (1, 19, 32) . The total lack of antimicrobial activity of spectinomycin derivatives altered at the 9-position (4, 11, 12, 30) , which were synthesized to overcome enzymatic inactivation, shows the significance of the 9-hydroxyl group for the binding of the 30S subunit.
Very little is known about the transport of spectinomycin into the bacterial cell. However, it is of interest that the two compounds lacking the streptamine moiety, spectinomycin and kasugamycin, do not compete with the uptake of streptomycin, gentamicin, kanamycin, or neomycin via the polyamine transport system in E. coli K-12 (18) .
Among aminoglycosidic aminocyclitols, spectinomycin is of particular interest because it does not share the ototoxic and nephrotoxic properties of this antibiotic group (25) .
Improvement of spectinomycin properties for the therapy of Enterobacteriaceae infections, besides enhancement of antibiotic potency, involves reduction in spontaneous mutations, an increase in stability to enzymatic inactivation by adenyltransferase, and an altered transport system to bypass the membrane-bound inactivating enzyme. Derivatives of 4(R)-amino spectinomycin described in this paper are substituted on the 4-amino group and were prepared to achieve these properties. For the isolation of the mutant, 1012 cells of a 20-h culture were spread onto an agar plate. After incubation at 37°C, the bacteria were replicated onto agar plates containing spectinomycin at concentrations of 1, 5, 20, 30, 40, 50, 75 , and 100 ,ug/ml. The lowresistance mutant was isolated at a concentration of 30 ,ug of spectinomycin per ml.
MATERIALS AND METHODS
Chemicals. Spectinomycin was supplied by The Upjohn Co., Kalamazoo, Mich. The spectinomycin derivatives were prepared as described elsewhere (38) . The homogeneity of the compounds was assayed by thinlayer chromatography, microanalysis, and spectroscopy including UV, infrared, nuclear magnetic resonance, and mass spectroscopy spectra.
Antimicrobial activity. Minimal inhibitory concentration (MIC) values were determined by means of a broth dilution test, using an inoculum of 104 colonyforming units in a medium of 5 g of peptone and 3 g of meat extract in 1 liter of distilled water at pH 6.8. Preparation of adenyltransferase. To achieve a high yield of adenyltransferase, E. coli DB 10/222 was subcultured five times onto agar containing 2 mg of spectinomycin per ml. After a 16-h fermentation of the resistant E. coli strain in a 10-liter Biostat fermentor, 20 g of cells was harvested, washed twice in 0.9% NaCl, and disrupted by sonication. After solution in 10 ml of 10 mM Tris-hydrochloride (pH 7.1) with 5 mM mercaptoethanol, the suspension was centrifuged at 40,000 x g for 30 min. The supernatant was dialyzed at 4°C for 72 h in 10 mM Tris-hydrochloride (pH 7.5) containing 6 mM mercaptoethanol. The protein content was determined as 30 mg/ml. Enzyme activity was stable for 2 months at -80°C.
Adenyltransferase assay. The adenyltransferase assay method was modified slightly from that of Benveniste et al. (1) . The 4 min to stop the reaction, rinsed five times in 500 ml of distilled water, dried, and placed in Instagel 1 for liquid scintillation counting. The Km and Vmax values were calculated from enzyme kinetic curves (8, 37) .
Estimation of lipophilicity. For the estimation of lipophilicity, a physicochemical parameter for structural improvement, the log P values of derivatives 25 and 26, which display UV absorption, were measured. These data were used for calculating the theoretical log P values of other derivatives. The substance was dissolved in pH 9.0 phosphate buffer at a concentration of 2.5 mg per 5 ml and then extracted in 2 ml of octanol. The mixture was shaken for 30 min at room temperature and centrifuged at 2,500 x g for 10 min. The absorption of the aqueous phase at 242 nm was measured, and the concentration of the derivative was calculated by means of a standard curve. Log P of 4(R)-amino spectinomycin was obtained by subtracting the wr value, calculated for the acyl side chain (16) , from the log P measured for compound 25 . The lipophilicity of the other derivatives was obtained by adding the calculated rr value to the log P value of spectinomycylamine.
RESULTS
The partition coefficient of compound 25 was determined in triplicate as log P = 1.07 ± 0.001. The log P (-1.73) for compound 1 (spectinomycylamine) was calculated by subtracting the theoretical Tr value 2.80 of the substituent. The partition coefficient for compound 26 was determined in triplicate assays as log P = 2.15 + 0.001. However, the calculated log P is equal to 4.31 on the basis of iT = 0.54 for CH2 groups. This discrepancy may be due to folding or balling of long alkyl side chains which reduces the observed lipophilicity. This observation is in agreement with other investigations (21, 27, 35) , in which the IT value for CH2 in alkyl chains longer than 7 carbon atoms was observed to be 0.37. Therefore, for CH2 substituents in alkyl chains with more than 7 carbon atoms, r = 0.37 was employed in the calculations. If the estimation of log P for compound 26 is based on these results, a theoretical log P of 2.27 is obtained, which is in good agreement with the observed log P.
The lipophilicity, the Km and Vm,, values determined for adenyltransferase as well as the relative Km and Vmax, and the MIC values for susceptible and resistant E. coli strains of the synthesized 4(R)-amino spectinomycin derivatives (see Fig. 1 From the spectrum of activity of compound 3, with an isopropyl substitution, against E. coli spec 7 and spec 13, it appeared that this derivative possessed a binding site different from that of spectinomycin. In contrast, the isoamyl substitution in compound 5 displayed a significantly weaker activity against the investigated strains. Even E. coli DB 10, with a higher permeability to spectinomycin, was only significantly inhibited by compound 5 at pH 8.6, with a 20-foldlower MIC value than at pH 6.8.
In general, the influence of the pH on the antimicrobial activity of the derivatives was only present up to a chain length of 11 carbon atoms. A comparison of the MIC values of such compounds, namely, 1-7, 10-14, 18, 19, 22, 25, 27, and 28, against E. coli DB 10 and E. coli ATCC %37 suggests that their ability to penetrate into the bacterial cell was insufficient to affect ribosomal function at lower concentrations. Substitution of the carbonyl function by an amino group in the 4-position of spectinomycin, as in compounds 27 and 28, caused a decrease in the MIC against both the wild-type strain and the low-resistance mutant E. coli LR 53. Thus the substitution appeared to facilitate penetration of the compound into the cell.
Comparable to compound 5, the acylated derivative number 10 possessed very weak activity against E. coli DB 10 unless the pH was raised to pH 8.6. The influence of pH on the antimicrobial activity decreased with an increase of the side chain length of the acylaminospectinomycins from 9 carbon atoms upwards. This correlated also with a decreased affinity for adenyltransferase and therefore with an increase in the relative ratio of Km.Vma.
Mainly due to their peptide bonds, in the carboxamidoacyl aminospectinomycins, the substituents were significantly less lipophilic than comparable chain length substituents of other derivatives. However, the antimicrobial activity of derivatives with longer side chains was considerably increased and was insensitive to pH changes. Compound 22 did not follow this tendency, since the activity against wild-type strains was rather low despite its side chain length. However, activity against susceptible E. coli strain DB 10 was comparable to that of the other long-side-chain derivatives.
In general, the adenyltransferase affinity, with the exception of compound 22, was decreased in compounds substituted with a C12H25 side chain or with even more carbon atoms.
Compared to spectinomycin, amino acylaminospectinomycins with short-side-chain substitution (compounds 27 and 28) demonstrated an increase in their activity for susceptible strains as well as for target site-resistant E. coli strains spec 7 and spec 13. The influence of the pH on the activity was still present. However, the effect of the R-plasmid-carrying strain was rather weak, corresponding to the Km values for adenyltransferase, which were little changed.
DISCUSSION
The antimicrobial activities of these spectinomycin derivatives indicated that the longer chain length of the substituent, the greater the potency. With few exceptions (for example, compound 14, although possessing a lower log P and hence lower lipophilicity, expressed an equal or greater potency than compound 7), the strength of activity correlated with chain length as well as with lipophilicity. On the other hand, substitution with a side chain longer than 11 carbon atoms did not further increase the activity. Substitution with short-side-chain alkyl and acyl residues up to 9 carbon atoms in the aliphatic part of the substituent did not improve the molecule with respect to spectinomycin. In contrast, substitution with short-chain aminoacyl residues resulted in compounds more active than spectinomycin. This implies that the free amino group in these derivatives was responsible for the increased activity. The fact that substitution of the terminal amino group by one or two methyl groups reduced the antimicrobial activity supports this conclusion.
The decrease in the activity of compound 22, which possessed a side chain of 18 carbon atoms additional to the 6 carbon atoms in the acyl group, may result from steric hindrance during VOL. 21, 1982 on January 27, 2018 by guest http://aac.asm.org/ Downloaded from Km and Vmx values for affinity and reaction velocity of adenyltransferase and MIC values against wild-type E. coli 9637, susceptible E. coli DB 10 at pH 6.8 and pH 8.6, E. coli DB 10 containing R-plasmid 222, low-resistant mutant LR 53, and target site-resistant strains E. coli spec 7 and spec 13. penetration. This suggestion is supported by its relatively strong inhibitory effect against E. coli DB 10 which has a lower permeability barrier to spectinomycin than the wild-type or resistant strains.
The strong inhibitory effects of the long-sidechain derivatives appeared to be due to a different binding site than spectinomycin, as evidenced by their activity against target siteresistant E. coli spec 7 and spec 13. With the exception of compound 7, the antimicrobial activity of these compounds was not dependent on the pH as was characteristic for spectinomycin and 4(R)-amino spectinomycin derivatives with short side chains.
That this antimicrobial activity might be due to a nonspecific action of the long carbon side chains on proteins can be excluded in analogy to streptomycin derivatives. In a series of aliphatic streptomycylamines, a typical isotope dilution curve for competition with dihydrostreptomycin for binding to ribosomes demonstrated that the long-chain streptomycylamines show specific binding to the ribosome (17) .
These investigations imply that activity of 4(R)-amino spectinomycin derivatives against resistant strains can be achieved by compounds with long-side-chain substitutions. Such compounds are relatively insensitive to adenyltransferase modification, effective against low-resistance mutants probably blocked in spectinomycin uptake, and active against high-resistance mutants with altered ribosomes.
Compounds 7-9, 14-17, 20-21, 23-24, and 26 displayed potent antimicrobial properties which make them suitable for further development. 
